Sickle cell and α+-thalassemia traits influence the association between ferritin and hepcidin in rural Kenyan children aged 14-26 months

Journal of Nutrition

Volumn 148, Issue 12, 2018, Pages 1903-1910

  Byrd, Kendra A ^a   Williams, Thomas N ^b,c   Lin, Audrie ^d   Pickering, Amy J ^e   Arnold, Benjamin F ^d   Arnold, Charles D ^a   Kiprotich, Marion ^f   Dentz, Holly N ^a,f   Njenga, Sammy M ^g   Rao, Gouthami ^f   Colford, John M ^d   Null, Clair ^h   Stewart, Christine P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST MARY S HOSPITAL   (United Kingdom)

^c KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Tufts University   (United States)

^f INNOVATIONS FOR POVERTY ACTION   (United States)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^h MATHEMATICA POLICY RESEARCH   (United States)

Author keywords

Ferritin; Hepcidin; Iron status; Sickle cell; + thalassemia

Indexed keywords

FERRITIN; HEPCIDIN; HEMOGLOBIN A; HEMOGLOBIN AA;

ALPHA THALASSEMIA; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENETIC POLYMORPHISM; HUMAN; KENYA; KENYAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RURAL POPULATION; SICKLE CELL BETA THALASSEMIA; SICKLE CELL TRAIT; BLOOD; GENETICS; INFANT; PRESCHOOL CHILD; SICKLE CELL ANEMIA;

ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; CHILD, PRESCHOOL; FEMALE; FERRITINS; HEMOGLOBIN A; HEPCIDINS; HUMANS; INFANT; MALE;

EID: 85061348062     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/nxy229     Document Type: Article

References (40)

1. Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med 2012;2(9):a011692.
2. Atkinson SH, Mwangi TW, Uyoga SM, Ogada E, Macharia AW, Marsh K, Prentice AM, Williams TN. The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium Falciparum malaria in children on the coast of Kenya. Clin Infect Dis 2007;44(6):802-9.
3. Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet 2012;12:457-68.
4. Williams TN. How do hemoglobins S and C result in malaria protection? J Infect Dis 2011;204(11):1651-3.
5. Foote EM, Sullivan KM, Ruth LJ, Oremo J, Sadumah I, Williams TN, Suchdev PS. Determinants of anemia among preschool children in rural, western Kenya. Am J Trop Med Hyg 2013;88(4):757-64.
6. Thorup OA. Fundamentals of clinical hematology. Chicago, Illinois: WB Saunders Company; 1987.
7. WHO. Daily iron supplementation in infants and children. Geneva (Switzerland): WHO; 2016.
8. Namaste SM, Rohner F, Huang J, Bhushan NL, Flores-Ayala R, Kupka R, Mei Z, Rawat R, Williams AM, Raiten DJ. Adjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Am J Clin Nutr 2017;106(Suppl 1):359S-71S.
9. WHO. Assessing iron status of populations. 2nd ed. Geneva (Switzerland): WHO; 2007.
10. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003;329(1-2):9-22.
11. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011;117(17):4425-33.
12. Ganz T, Nemeth E. Iron metabolism: interactions with normal and disordered erythropoiesis. Cold Spring Harb Perspect Med 2012;2(5):a011668.
13. Ganz T. Systemic iron homeostasis. Physiol Rev 2013;93:1721-41.
14. Lawen A, Lane DJ. Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action. Antioxid Redox Signal 2013;18(18):2473-507.
15. Ginzburg Y, Rivella S. Beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011;118(16):4321-30.
16. Zimmermann MB, Fucharoen S, Winichagoon P, Sirankapracha P, Zeder C, Gowachirapant S, Judprasong K, Tanno T, Miller JL, Hurrell RF. Iron metabolism in heterozygotes for hemoglobin E (HbE), α-thalassemia 1, or β-thalassemia and in compound heterozygotes for HbE/β-thalassemia. Am J Clin Nutr 2008;88(4):1026-31.
17. Pasricha SR, McHugh K, Drakesmith H. Regulation of hepcidin by erythropoiesis: the story so far. Ann Rev Nutr 2016;36:417-34.
18. Guimarães JS, Cominal JG, Silva-Pinto AC, Olbina G, Ginzburg YZ, Nandi V, Westerman M, Rivella S, de Souza AM. Altered erythropoiesis and iron metabolism in carriers of thalassemia. Eur J Hematol 2015;94(6):511-8.
19. Gibson RS, Bailey KB, Williams S, Houghton L, Costa-Ribeiro HC, Mattos AP, Barreto DL, Lander RL. Tissue iron deficiency and adiposity-related inflammation in disadvantaged preschoolers from NE Brazil. Eur J Clin Nutr 2014;68(8):887-91.
20. Arnold BF, Null C, Luby SP, Unicomb L, Stewart CP, Dewey KG, Ahmed T, Ashraf S, Christensen G, Clasen T, et al. Cluster-randomized controlled trials of individual and combined water, sanitation, hygiene and nutritional interventions in rural Bangladesh and Kenya: the WASH Benefits study design and rationale. BMJ Open 2013;3:e003476.
21. Null C, Stewart CP, Pickering AJ, Dentz HN, Arnold BF, Arnold CD, Benjamin-Chung J, Clasen T, Dewey KG, Fernald LCH, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Kenya: a cluster-randomised controlled trial. Lancet Glob Health 2018;6(3):PE316-29.
22. WHO. Haemoglobin concentrations for the diagnosis of anemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva (Switzerland): WHO; 2011.
23. Erhardt JG, Estes JE, Pfeiffer CM, Biesalski HK, Craft NE. Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique. J Nutr 2004;134(11):3127-32.
24. Suchdev PS, Namaste SM, Aaron GJ, Raiten DJ, Brown KH, Flores-Ayala R, Group BW. Overview of the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) Project. Adv Nutr 2016;7(2):349-56.
25. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 2000;95(1):360-2.
26. Waterfall CM, Cobb BD. Single tube genotyping of sickle cell anaemia using PCR-based SNP analysis. Nucleic Acids Res 2001;29(23): E119.
27. Gomez S, Diawara A, Gbeha E, Awadalla P, Sanni A, Idaghdour Y, Rahimy MC. Comparative analysis of iron homeostasis in sub-Saharan african children with sickle cell disease and their unaffected siblings. Front Pediatr 2016;4:8.
28. Jaeggi T, Moretti D, Kvalsvig J, Holding PA, Tjalsma H, Kortman GA, Joosten I, Mwangi A, Zimmermann MB. Iron status and systemic inflammation, but not gut inflammation, strongly predict gender-specific concentrations of serum hepcidin in infants in rural Kenya. PloS One 2013;8(2):e57513.
29. Mupfudze TG, Stoltzfus RJ, Rukobo S, Moulton LH, Humphrey JH, Prendergast AJ; The Shine Project Team. Hepcidin decreases over the first year of life in healthy African infants. Br J Haematol 2014;164(1):150-3.
30. Atkinson SH, Uyoga SM, Armitage AE, Khandwala S, Mugyenyi CK, Bejon P, Marsh K, Beeson JG, Prentice AM, Drakesmith H, et al. Malaria and age variably but critically control hepcidin throughout childhood in Kenya. EBioMedicine 2015;2(10):1478-86.
31. Uijterschout L, Swinkels DW, Domellof M, Lagerqvist C, Hudig C, Tjalsma H, Vos R, van Goudoever JB, Brus F. Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5-3 y. Pediatr Res 2014;76(4):409-14.
32. Atkinson S, Armitage AE, Khandwala S, Mwangi TW, Uyoga SM, Bejon PA, Williams TN, Prentice AM, Drakesmith H. Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children. Blood 2014;123(21):3221.
33. Jones E, Pasricha S-R, Allen A, Evans P, Fisher CA, Wray K, Premawardhena A, Bandara D, Perera A, Webster C. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. Blood 2015;125(5):873-80.
34. Camaschella C, Nai A. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias. Br J Haematol 2016;172(4):512-23.
35. Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in beta-thalassemia. Hematol Oncol Clin North Am 2010;24(6):1089-107.
36. Rivella S. The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia. Blood Rev 2012;26:S12-S5.
37. Karafin MS, Koch KL, Rankin AB, Nischik D, Rahhal G, Simpson P, Field JJ. Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease. Blood Cells Mol Dis 2015;55(4):304-7.
38. Suominen P, Virtanen A, Lehtonen-Veromaa M, Heinonen OJ, Salmi TT, Alanen M, Möttönen T, Rajamäki A, Irjala K. Regression-based reference limits for serum transferrin receptor in children 6 months to 16 years of age. Clin Chem 2001;47(5):935-7.
39. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genetics 2014;46(7):678.
40. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science 2012;338(6108):768-72.